Biofrontera (BFRI) Accounts Payables (2020 - 2025)

Biofrontera's Accounts Payables history runs 6 years deep, the most recent figure standing at $4.8 million for Q4 2025.

• On a quarterly basis, Accounts Payables rose 159.21% year-over-year to $4.8 million in Q4 2025; TTM through Dec 2025 was $4.8 million, a 159.21% increase from a year earlier, with the FY2025 full-year figure at $4.8 million, up 159.21% from the prior year.
• Accounts Payables rose to $4.8 million in Q4 2025 per BFRI's latest filing, from $2.1 million in the prior quarter.
• Across five years, Accounts Payables topped out at $4.8 million in Q4 2025 and bottomed at $100000.0 in Q1 2024.
• The 5-year median for Accounts Payables is $931000.0 (2022), against an average of $1.5 million.
• Across the five-year window, Accounts Payables slumped 88.73% in 2024 and jumped 4168.0% in 2025, its largest moves.
• Year by year, Accounts Payables stood at $658000.0 in 2021, then surged by 99.39% to $1.3 million in 2022, then soared by 152.13% to $3.3 million in 2023, then plunged by 43.89% to $1.9 million in 2024, then surged by 159.21% to $4.8 million in 2025.
• Per Business Quant, the three latest BFRI Accounts Payables figures stand at $4.8 million (Q4 2025), $2.1 million (Q3 2025), and $4.3 million (Q2 2025).